Search

Search Results

• A Case of M-Paraprotein-Associated Polyneuropathy with Stable Response to Rituximab Therapy

  Vsevolod Gennad’evich Potapenko, V.N. Kiselev

  434-437

  01.10.2019

• Clinical and Laboratory Characteristics and Differential Diagnosis between Secondary Hemophagocytic Syndrome and Sepsis

  Vsevolod Gennad’evich Potapenko, M.Yu. Pervakova, A.V. Titov, O.V. Goloshchapov, S.V. Lapin, E.A. Surkov, A.V. Klimovich, O.P. Mironova, N.N. Petrova, N.Yu. Chernookaya, E.V. Karyagina, N.V. Skorobogatova, E.S. Pavlyuchenko, E.A. Karev, N.A. Potikhonova, V.A. Dubkova, A.Yu. Kaskov, A.V. Rysev, T.G. Kulibaba, N.V. Medvedeva

  329-337

  01.07.2019

• WT1 Gene Overexpression in Differential Diagnosis of Ph-negative Myeloproliferative Disorders

  E.G. Lomaia, Nadiya Tamazovna Siordiya, E.G. Lisina, O.M. Senderova, A.A. Silyutina, A.Yu. Zaritskey

  297-302

  01.07.2019

• Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

  Elena Romanovna Shilova, T.V. Glazanova, Zh.V. Chubukina, O.E. Rozanova, M.N. Zenina, A.V. Seltser, V.I. Rugal, V.A. Balashova, V.A. Kobilyanskaya, I.I. Krobinets, V.Yu. Udal’eva, I.I. Zotova, L.V. Stelmashenko, N.A. Romanenko, T.B. Zamotina, I.V. Khorsheva, S.V. Voloshin

  319-328

  01.07.2019

• TP53 Gene Mutations in Tumor Cells of Patients with Aggressive B-Cell Lymphomas

  Anna Evgen’evna Misyurina, S.K. Kravchenko, V.A. Misyurin, A.M. Kovrigina, A.U. Magomedova, E.A. Baryakh, F.E. Babaeva, A.V. Misyurin

  263-270

  01.07.2019

• The Use of Ibrutinib in Refractory Chronic Lymphocytic Leukemia and in High-Risk Patients

  Nadezhda Viktorovna Kurkina, E.A. Repina, N.N. Mashnina

  278-281

  01.07.2019

• Primary Bone Lymphomas: Long-Term Results of a Prospective Single-Center Trial

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, V.E. Mamonov, S.A. Tatarnikova, L.G. Gorenkova, D.S. Badmadzhapova, A.M. Kovrigina, E.G. Gemdzhian, E.E. Zvonkov

  247-262

  01.07.2019

• Clinical Value of miR-3151 Overexpression in Synergistic Interaction with BAALC Host Gene in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

  Alena Igorevna Shakirova, I.M. Barkhatov, A.I. Churkina, N.N. Mamaev, L.S. Zubarovskaya, B.V. Afanas’ev

  303-308

  01.07.2019

• Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

  Vladimir Ivanovich Vorob’ev, V.A. Zherebtsova, E.I. Dubrovin, L.A. Bychenkova, Yu.B. Kochkareva, L.A. Mukha, V.L. Ivanova, N.K. Khuazheva, V.V. Ptushkin

  165-172

  01.04.2019

• Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina

  154-164

  01.04.2019

• A Clinical and Pathological Comparison of Different Immunomorphological Subvariants of Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma at Initial Diagnosis

  Irina Aleksandrovna Shupletsova, A.M. Kovrigina, T.N. Moiseeva, E.I. Dorokhina, S.M. Kulikov

  185-193

  01.04.2019

• Bispecific Antibodies in Clinical Practice and Clinical Trials (Literature Review)

  O.N. Solopova, Vsevolod Andreevich Misyurin

  125-144

  01.04.2019

• Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

  Sergei Nikolaevich Bondarenko, E.N. Parovichnikova, A.A. Maschan, O.Yu. Baranova, T.V. Shelekhova, V.A. Doronin, V.Ya. Mel’nichenko, K.D. Kaplanov, O.S. Uspenskaya, A.N. Sokolov, N.V. Myakova, I.S. Moiseev, I.V. Markova, E.I. Darskaya, A.G. Smirnova, T.A. Bykova, B.I. Ayubova, I.A. Samorodova, E.V. Babenko, I.M. Barkhatov, T.L. Gindina, A.D. Kulagin, B.V. Afanas’ev

  145-153

  01.04.2019

• Rhythm and Conduction Disorders in Patients Receiving Ibrutinib

  E.I. Emelina, Gennadii Efimovich Gendlin, I.G. Nikitin, E.A. Dmitrieva, E.A. Nikitin, V.V. Ptushkin

  220-230

  01.04.2019

• Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome

  Sergei Vasil’evich Gritsaev, I.I. Kostroma, A.A. Zhernyakova

  120-124

  01.04.2019

• Prognostic Value of PRAME Activity in Tumor Cells of Follicular Lymphoma

  Vsevolod Andreevich Misyurin, A.E. Misyurina, S.K. Kravchenko, N.A. Lyzhko, Yu.P. Finashutina, N.N. Kasatkina, D.S. Mar’in, E.S. Nesterova, N.N. Sharkunov, M.A. Baryshnikova, A.V. Misyurin

  173-178

  01.04.2019

• Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)

  Yuliya Eikhenovna Vinogradova, N.G. Chernova

  179-184

  01.04.2019

• Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)

  Oleg Aleksandrovich Shukhov, A.G. Turkina, E.Yu. Chelysheva, A.V. Bykova, A.N. Petrova, G.A. Gusarova, I.S. Nemchenko, A.O. Abdullaev, T.N. Obukhova, A.B. Sudarikov

  194-201

  01.04.2019

• Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations)

  Ekaterina Yur’evna Chelysheva, A.G. Turkina, E.S. Polushkina, M.A. Vinogradova, R.G. Shmakov

  202-210

  01.04.2019

• Achievements and Challenges in Allogeneic Hematopoietic Stem Cell Transplantation in Cytogenetically Unfavorable Acute Leukemias (Literature Review)

  Nikolai Nikolaevich Mamaev, T.L. Gindina, B.V. Afanas’ev

  111-119

  01.04.2019

• Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)

  Ekaterina Vadimovna Motyko, O.V. Blau, L.B. Polushkina, L.S. Martynenko, M.P. Bakai, N.Yu. Tsybakova, Yu.S. Ruzhenkova, E.V. Kleina, N.B. Pavlenko, A.M. Radzhabova, E.V. Karyagina, O.S. Uspenskaya, S.V. Voloshin, A.V. Chechetkin, I.S. Martynkevich

  211-219

  01.04.2019

• Practical Aspects of the Use of Carfilzomib in Multiple Myeloma

  Sergei Vyacheslavovich Semochkin, G.N. Salogub, S.S. Bessmeltsev, K.D. Kaplanov

  21-31

  01.01.2019

• Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

  Svetlana Valer’evna Samarina, E.L. Nazarova, N.V. Minaeva, E.N. Zotina, I.V. Paramonov, S.V. Gritsaev

  68-72

  01.01.2019

• Prognostic Value of the PRAME Gene Expression in T-Cell Lymphoproliferative Disorders

  E.A. Penskaya, Vsevolod Andreevich Misyurin, A.E. Misyurina, S.K. Kravchenko, L.G. Gorenkova, L.V. Plastinina, V.V. Tikhonova, Yu.P. Finashutina, N.A. Lyzhko, N.N. Kasatkina, L.A. Kesaeva, O.N. Solopova, A.V. Misyurin

  73-78

  01.01.2019

• Clinical and Prognostic Value of Molecular Markers of Diffuse Large B-Cell Lymphoma

  S.M. Rastorguev, D.A. Koroleva, E.S. Boulygina, S.V. Tsygankova, N.G. Goncharov, O.S. Naraikin, N.G. Gabeeva, E.E. Zvonkov, A.V. Nedoluzhko

  95-100

  01.01.2019

• Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Experience in Treating 131 Patients at a National Medical Research Center in Russia

  I.Z. Zavodnova, M.Yu. Kichigina, E.V. Paramonova, Yu.E. Ryabukhina, O.A. Kolomeitsev, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, N.V. Kokosadze, Gayane Sergeevna Tumyan

  59-67

  01.01.2019

• Epidemiology of Multiple Myeloma in Novosibirsk (Siberian Federal District)

  Nataliya Valer’evna Skvortsova, T.I. Pospelova, I.B. Kovynev, G.S. Soldatova, I.N. Nechunaeva

  86-94

  01.01.2019

• Clinical Experience and Perspectives of Bosutinib Use in Patients with Chronic Myeloid Leukemia

  V.A. Shuvaev, Ol’ga Yur’evna Vinogradova, I.S. Martynkevich, N.V. Novitskaya, M.S. Fominykh, S.N. Tsareva, D.I. Shikhbabaeva, M.M. Pankrashkina, M.V. Chernikov, N.N. Sharkunov, I.I. Zotova, V.Yu. Udal’eva, E.V. Motyko, S.V. Voloshin

  288-294

  01.10.2018

• Expression of the BCR-ABL1 Gene in Patients with Chronic Myeloproliferative Diseases with Signs of Progression

  L.A. Kesaeva, E.N. Misyurina, D.S. Mar’in, E.I. Zhelnova, A.Yu. Bulanov, A.E. Misyurina, A.A. Krutov, I.N. Soldatova, S.S. Zborovskii, V.A. Misyurin, V.V. Tikhonova, Yu.P. Finashutina, O.N. Solopova, N.A. Lyzhko, A.E. Bespalova, N.N. Kasatkina, A.V. Ponomarev, M.A. Lysenko, Andrei Vital’evich Misyurin

  354-359

  01.10.2018

• Erythrodermic Mycosis Fungoides: The Algorithm of Diagnosis and Treatment

  O.Yu. Olisova, A.A. Sydikov, I.N. Chuprov, L.G. Gorenkova, S.A. Chernysh, V.A. Doronin, Ekaterina Vladimirovna Grekova

  295-302

  01.10.2018

• The Use of Pomalidomide in the Treatment of Relapsed/Refractory Multiple Myeloma in Patients with Renal Failure

  Irina Germanovna Rekhtina, M.V. Nareiko, L.P. Mendeleeva

  283-287

  01.10.2018

• Immune Checkpoint Inhibitors in the Treatment of Lymphomas

  Kirill Viktorovich Lepik

  303-312

  01.10.2018

• Immunological Synapse in the Biology of Chronic Lymphocytic Leukemia

  Darima Semunkoevna Badmazhapova, I.V. Gal’tseva, E.E. Zvonkov

  313-318

  01.10.2018

• EBV-Positive Lymphoproliferative Diseases: A New Concept and Differential Diagnosis (Literature Review and Case Reports)

  Alla Mikhailovna Kovrigina

  326-337

  01.10.2018

• Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients

  Maksim Valer’evich Solov’ev, L.P. Mendeleeva, G.A. Yatsyk, N.S. Lutsik, M.V. Firsova, E.G. Gemdzhian, V.G. Savchenko

  360-367

  01.10.2018

• Correlation of CD34+ Hematopoietic Stem Cells and CFU in Peripheral Blood Apheresis Products in Patients with Malignant Lymphoproliferative Diseases Before and After Cryopreservation Prior to auto-HSCT

  Valentina Andreevna Balashova, V.I. Rugal’, S.S. Bessmel’tsev, S.V. Gritsaev, N.Yu. Semenova, S.V. Voloshin, Zh.V. Chubukina, A.V. Shmidt, A.D. Garifullin, I.M. Zapreeva, A.A. Kuzyaeva, I.I. Kostroma, A.Yu. Kuvshinov, A.V. Chechetkin

  368-377

  01.10.2018

• Cardiovascular Toxicity of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia

  I.L. Davydkin, Kseniya Viktorovna Naumova, A.M. Osadchuk, I.A. Zolotovskaya, O.E. Danilova, T.Yu. Stepanova, O.V. Tereshina, L.V. Limareva, A.S. Shpigel’, T.P. Kuz’mina

  378-387

  01.10.2018

• Pure Red Cell Aplasia with M-Gradient: A Literature Review and Clinical Experience

  Aleksandr Vasil’evich Pivnik, A.A. Petrenko, S.V. Kozhurin, S.A. Mar’ina

  273-280

  01.07.2018

• Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Diagnostics of Extramediastinal Lesions and Treatment Opportunities

  Yana Konstantinovna Mangasarova, A.U. Magomedova, A.M. Kovrigina, I.E. Kostina, E.S. Nesterova, L.G. Gorenkova, A.E. Misyurina, O.V. Margolin, S.K. Kravchenko

  220-226

  01.07.2018

• Results of Molecular Monitoring in Posttransplant Period by Means of Series Investigation of WT1 Gene Expression in Patients with Acute Myeloid Leukemia

  Ya.V. Gudozhnikova, Nikolai Nikolaevich Mamaev, I.M. Barkhatov, V.A. Katerina, T.L. Gindina, A.I. Shakirova, S.N. Bondarenko, O.A. Slesarchuk, E.I. Darskaya, O.V. Paina, L.S. Zubarovskaya, B.V. Afanas’ev

  241-251

  01.07.2018